دورية أكاديمية

Body weight changes after adjuvant chemotherapy of patients with breast cancer: results of a Mexican cohort study.

التفاصيل البيبلوغرافية
العنوان: Body weight changes after adjuvant chemotherapy of patients with breast cancer: results of a Mexican cohort study.
المؤلفون: Vargas‐Meza, A., Chavez‐Tostado, M., Cortes‐Flores, A.O., Urias‐Valdez, D., Delgado‐Gomez, M., Morgan‐Villela, G., Zuloaga‐Fernandez Del Valle, C., Jimenez‐Tornero, J., Zuloaga‐Fernandez Del Valle, R., Fuentes‐Orozco, C., García‐Rentería, J., Rendón‐Félix, J., Cuesta‐Márquez, L., Gonzalez‐Ojeda, A.
المصدر: European Journal of Cancer Care; Sep2017, Vol. 26 Issue 5, pn/a-N.PAG, 7p, 3 Charts
مصطلحات موضوعية: ANTHROPOMETRY, BODY weight, BREAST tumors, CHI-squared test, COMBINED modality therapy, CONFIDENCE intervals, INGESTION, LONGITUDINAL method, MULTIVARIATE analysis, T-test (Statistics), WEIGHT loss, PERIMENOPAUSE, RETROSPECTIVE studies, POSTMENOPAUSE, DATA analysis software, INFERENTIAL statistics, ODDS ratio
مصطلحات جغرافية: MEXICO
مستخلص: Weight gain is observed in breast cancer patients receiving chemotherapy and is a well-known complication. Several factors that contributing to weight gain have been identified. However, there is a lack of information about factors associated with weight changes following adjuvant chemotherapy. A retrospective cohort of 200 pre- and post-menopausal Mexican patients treated for breast cancer was made. Anthropometric variables were measured before/after treatment. Biomarkers, cellular differentiation and chemotherapy were similar between groups. Weight gain occurred in 85.6% of pre-menopausal and 72.6% of post-menopausal women ( p = .03). At the end of chemotherapy, weight and body mass index ( BMI) did not differ significantly between pre-menopausal (69.3 ± 12.6 kg; 26.6 ± 4.8 kg/m2) and post-menopausal women (69.5 ± 10.9 kg; 27.3 ± 4.4 kg/m2) ( p = .91 and 0.34). Dexamethasone doses were higher in pre-menopausal (85.7 ± 39.1 g) than post-menopausal patients (79.2 ± 22.5 g; p = .13). Weight loss was observed in 9.2% of pre-menopausal and 20.2% of post-menopausal patients ( p = .04). A multivariate analysis revealed that age ( OR = 2.7; 95% CI = 1.26-5.79; p = .01), menopausal status ( OR = 2.29; 95% CI = 1.09-4.80; p = .03), dexamethasone dosage ( OR = 2.1; 95% CI = 1.04-4.23; p = .03) and daily caloric intake ( OR = 2.3; 95% CI = 1.12-5.10; p = .02) were independent variables that inducted weight gain. Pre- and post-menopausal women gained weight, but more pre-menopausal patients showed gain. An effort should be made to administer lower steroid doses to reduce weight gain. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Cancer Care is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09615423
DOI:10.1111/ecc.12550